Spontaneous Chylothorax (A Case Report)

Chylothorax is caused by the distruption or obstruction of the thoracic duct or its tributaries that result in leakage of chyle into the pleural space. A 3.5-year-old male patient without significant past medical history was admitted to the outpatient clinic of our hospital with persistent coughing. The initial chest radiograph demonstrated consolidation and effusion in the left lung upon which we performed thoracentesis. The pleural fluid had milk-white color. The biochemical analysis showed that its density was 1015 with pH: 7, glucose: 168 mg/dl, triglyceride: 2101 mg/dl, and WBC: 590/mm3. We started the treatment by offering a low-fat diet and somatostatin 3 μgr/kg/h. The chest tube was removed on the 25th day after the cessation of chylous pleural fluid from the tube in addition to the improvement that was visible on the chest radiograph; the patient was discharged. We would like to emphasize that chylothorax may occur very rarely but spontaneously and the use of somatostatin therapy may reduce the need for surgical intervention

[1]  Arvind Kumar,et al.  Thoracoscopic ligation of thoracic duct for spontaneous chylothorax. , 2013, Indian pediatrics.

[2]  J. Moreira-Pinto,et al.  Octreotide in the treatment of neonatal postoperative chylothorax: report of three cases and literature review , 2011, Pediatric Surgery International.

[3]  P. Shah,et al.  Octreotide for the treatment of chylothorax in neonates. , 2010, The Cochrane database of systematic reviews.

[4]  J. Massie,et al.  Chylothorax: diagnosis and management in children. , 2009, Paediatric respiratory reviews.

[5]  A. Bulbul,et al.  Idiopathic congenital chylothorax presented with severe hydrops and treated with octreotide in term newborn , 2009, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[6]  J. Bines,et al.  Post‐operative chylothorax in children: An evidence‐based management algorithm , 2008, Journal of paediatrics and child health.

[7]  B. Frey,et al.  The role of somatostatin in the treatment of persistent chylothorax in children. , 2006, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[8]  J. Ryu,et al.  Etiology of chylothorax in 203 patients. , 2005, Mayo Clinic proceedings.

[9]  A. Kalangos,et al.  Etiology and management of pediatric chylothorax. , 2000, The Journal of pediatrics.

[10]  R. Burger,et al.  Chylothorax in children: guidelines for diagnosis and management. , 1999, Chest.

[11]  J. Fragata,et al.  Octreotide--additional conservative therapy for postoperative chylothorax in congenital heart disease. , 2009, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.